SETD1A, a lysine-methyltransferase (lysine-methyltransferase), has been shown to be a risk gene for schizophrenia associated with cognitive impairment, and its mutation increases the risk of schizophrenia (Mukai et al. 2019; Singh et al. 2016). Here, SETD1A is linked to schizophrenia.